OCL Vision Secures Multi-Million Pound Investment to Revolutionize Eye Care
In a significant move poised to reshape the ophthalmic landscape, OCL Vision, a London-based leader in eye care, has successfully attracted a multi-million pound investment from BGF. While the exact figures of this funding deal remain undisclosed, the strategic backing from BGF's London investment team—led by Alistair Brew, Karolina Sokolowska, and Dylan Kaye—signals a bold affirmation of confidence in OCL Vision's growth trajectory. This infusion of capital will be directed towards expanding the company’s operational footprint and enhancing its marketing and sales efficacy to drive further organic growth.
Founded by visionary ophthalmologists Ali Mearza, Allon Barsam, and Romesh Angunawela—later joined by Chien Wong—OCL Vision has carved a niche within the health care sector.
With a robust team comprising 12 surgeons and an overall workforce of 60, the company has made impressive strides, boasting double-digit growth in both patient numbers and revenue as of 2024. OCL Vision offers a comprehensive array of specialized ophthalmic procedures, ranging from vital clinical interventions like cataract and glaucoma surgeries to elective services such as laser vision correction and refractive lens replacement. Their commitment to excellence is reflected in their delivery of nearly 4,000 private procedures annually.
Further strengthening its leadership, OCL Vision has recently welcomed Nicholas Rudge as CEO and Darren Millington as CFO, alongside Suzanne Lawrence who joins as non-executive Chair through BGF’s Talent Network. This strategic leadership enhancement underscores OCL's commitment to pushing boundaries and achieving unparalleled growth in the ophthalmic field. With this new funding and dynamism within its executive team, OCL Vision is undoubtedly well-positioned to attract the attention of potential investors eager to support innovation in health care.
Click here for a full list of 6,908+ startup investors in the UK